Letter to the Editor

Interleukin-6 and statin therapy: potential role in the management of COPD

Robert P Young and Raewyn J Hopkins

For all author emails, please log on.

Respiratory Research 2013, 14:74 doi:10.1186/1465-9921-14-74

Published: 17 July 2013

Abstract (provisional)

We read with interest the article by Ferrari and colleagues, showing in a small prospective study of chronic obstructive pulmonary disease (COPD) patients, that interleukin-6 (IL-6) is a useful biomarker predicting worsening exercise tolerance and greater mortality [1]. We outline below the significance of this finding and its potential impact on the future management of COPD.

The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.